11篇
您的检索式：作者名="Gadeberg O"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial显示文摘 | Hagenbeek A Gadeberg O Johnson P | 2008 | Blood2008，111，12： | 1 |
| 2 | First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lympboma: Results of a phase Ⅰ/Ⅱ trial 显示文摘 | Hagenbeek A Gadeberg O Johnson P | 2008 | Blood2008，111，12： | 1 |
| 3 | First clinical use of ofatumumab,a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma:results of a phase 1/2 trial显示文摘 | Hagenbeek A Gadeberg O Johnson P | | 0，，12： | 1 |
| 4 | First clinical use of ofatumumab,a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma:results of a phase 1/2 trial显示文摘 | HAGENBEEK A GADEBERG O | 2008 | Blood2008，111，12： | 1 |
| 5 | First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal anti- body in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial显示文摘 | Hagenbeek A Gadeberg O Johnson P | 2008 | Blood2008，111，12： | 1 |
| 6 | First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: resultsofa phase 1/2 trial显示文摘 | HAGENBEEK A GADEBERG O JOHNSON P | 2008 | Blood2008，11，12： | 1 |
| 7 | First clinical use of ofatnmumab, a novel fully human anti-CD20 mon- oclonal antibody in relapsed or refractory follicular lymphoma: resuits of a phase 1/2 trial 显示文摘 | HAGENBEEK A GADEBERG O JOHNSON P | 2008 | Blood2008，111，12： | 1 |
| 8 | First clinical use of ofatumumab, a novel fully humananti-CD20 mono- clonal antibody in relapsed or refraetory follicular lymphoma: re- sultsofa phase 1/2 trial显示文摘 | HAGENBEEK A GADEBERG O JOHNSON P | 2008 | Blood2008，111，12： | 1 |
| 9 | First clinical use of atumumab,a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma:results of a phase Ⅰ/Ⅱ trial显示文摘 | Hagenbeek A Gadeberg O Johnson P | 2008 | Blood2008，111，12： | 1 |
| 10 | Chemoimmuno- therapy with ofatumumab in combination with CHOP in previ- ously untreated follicular lymphoma显示文摘 | Czuczman M S Hess G Gadeberg O V | 2012 | Br J Haematol2012，157，4： | 1 |
| 11 | First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial显示文摘 | Hagenbeek A Gadeberg O Johnson P | 2008 | Blood2008，111，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员